Translational PK–PD model for in vivo CAR‐T‐cell therapy delivered using CAR mRNA‐loaded polymeric nanoparticle vector
Abstract Autologous chimeric antigen receptor (CAR) T‐cell therapy has demonstrated remarkable response rates, yet its widespread implementation is hindered by logistical, financial, and physical constraints. Additionally, challenges such as poor persistence and allorejection are associated with all...
Saved in:
| Main Authors: | Se Jin Kim, Ganesh M. Mugundu, Aman P. Singh |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-12-01
|
| Series: | Clinical and Translational Science |
| Online Access: | https://doi.org/10.1111/cts.70101 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lung metastasis and recurrence is mitigated by CAR macrophages, in-situ-generated from mRNA delivered by small extracellular vesicles
by: Yuchen Xiao, et al.
Published: (2025-08-01) -
In vivo production of CAR T cell: Opportunities and challenges
by: Zhiqiang Song, et al.
Published: (2025-11-01) -
Novel mRNA-Engineered Fully Human CAR-T Cells Targeting AXL in Solid Tumors
by: Bo Zou, et al.
Published: (2025-04-01) -
An in vivo control map for the eukaryotic mRNA translation machinery
by: Helena Firczuk, et al.
Published: (2013-01-01) -
T cell-specific non-viral DNA delivery and in vivo CAR-T generation using targeted lipid nanoparticles
by: Jacek Lubelski, et al.
Published: (2025-07-01)